CN Patent

CN120187454A — β-肾上腺素能激动剂和毒蕈碱性拮抗剂组合物及使用方法

Assigned to Bonafield Health Co ltd · Expires 2025-06-20 · 1y expired

What this patent protects

本文公开了用于支持膀胱健康和/或治疗、改善、预防或减轻膀胱过度活动症或与其相关的症状的组合物。本文公开的组合物包含β‑肾上腺素能受体激动剂和至少一种毒蕈碱性受体拮抗剂。本文还描述了使用上述组合物的方法。

USPTO Abstract

本文公开了用于支持膀胱健康和/或治疗、改善、预防或减轻膀胱过度活动症或与其相关的症状的组合物。本文公开的组合物包含β‑肾上腺素能受体激动剂和至少一种毒蕈碱性受体拮抗剂。本文还描述了使用上述组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120187454A
Jurisdiction
CN
Classification
—
Expires
2025-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Bonafield Health Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.